Tissue distribution of basic drugs:: Accounting for enantiomeric, compound and regional differences amongst β-blocking drugs in rat

被引:101
作者
Rodgers, T [1 ]
Leahy, D
Rowland, M
机构
[1] Univ Manchester, Sch Pharm & Pharmaceut Sci, Ctr Appl Pharmacokinet Res, Manchester M13 9PL, Lancs, England
[2] Cyprotex, Macclesfield, Cheshire, England
基金
英国生物技术与生命科学研究理事会;
关键词
phospholipids; tissue partition; chirality; pharmacokinetics; physiological model; physicochemical properties; PBPK modelling; beta-blockers; partition coefficients;
D O I
10.1002/jps.20323
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this research was to identify the major factors controlling the distribution of beta-blockers (acebutolol, betaxolol, bisoprolol, metoprolol, oxprenolol, pindolol, propranolol and timolol) in rats, across tissues, compounds and enantiomers. Tissue distribution was assessed at steady state by infusing cassette doses of beta-blockers into the jugular vein via an indwelling catheter at a constant rate. Blood was sampled via an indwelling catheter in the carotid artery, and 12 tissues excised at the end of dose infusion (4 or 8 h). Drug concentrations were quantified using a novel chiral LC-MS method and the tissue-to-plasma (Kp) and tissue-to-plasma water (Kpu) values were calculated for each tissue. Differences between Kp were observed between many enantiomeric pairs, and largely explained by enantiomeric differences in plasma protein binding. Across compounds, Kpu values were generally highest in lung and lowest in adipose, and were higher for the more lipophilic drugs betaxolol and propranolol. For any tissue, Kpu differences between the individual beta-blockers correlated well with the corresponding affinity for blood cells. For all compounds, regional tissue distribution correlated well with tissue acidic phospholipid concentrations, with phosphatidylserine appearing to have the strongest influence. This information may be used as the basis for predicting the tissue distribution of basic drugs. (C) 2005 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:1237 / 1248
页数:12
相关论文
共 56 条
[11]   CHRONIC ARTERIAL AND VENOUS ACCESS IN THE UNRESTRAINED RAT [J].
BURT, ME ;
ARBEIT, J ;
BRENNAN, MF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 238 (04) :H599-H603
[12]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[13]   FATTY ACID COMPOSITION IN DEVELOPING RATS - FATTY ACID COMPOSITION OF TRIGLYCERIDES + PHOSPHOLIPIDS IN SOME ORGANS OF RAT DURING POSTNATAL DEVELOPMENT [J].
DOBIASOVA, M ;
HAHN, P ;
KOLDOVSKY, O .
BIOCHIMICA ET BIOPHYSICA ACTA, 1964, 84 (05) :538-&
[14]  
Dornbusch S.M., 1991, J RES ADOLESCENCE, V1, P19, DOI DOI 10.1111/1532-7795.EP11522650
[15]   Validation in pharmaceutical analysis. Part I: An integrated approach [J].
Ermer, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 24 (5-6) :755-767
[16]  
Fichtl B., 1991, ADV DRUG RES, P117
[17]  
Gargas M. L., 1991, CIIT ACTIVITIES, V11, P1
[18]   Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: Role of plasma protein and tissue phosphatidylserine binding [J].
Hanada, K ;
Akimoto, S ;
Mitsui, K ;
Mihara, K ;
Ogata, H .
PHARMACEUTICAL RESEARCH, 1998, 15 (08) :1250-1256
[19]   QUANTITATIVE RELATIONSHIPS BETWEEN STRUCTURE AND PHARMACOKINETICS OF BETA-ADRENOCEPTOR BLOCKING-AGENTS IN MAN [J].
HINDERLING, PH ;
SCHMIDLIN, O ;
SEYDEL, JK .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1984, 12 (03) :263-287
[20]   PHYSIOLOGICALLY-BASED PHARMACOKINETIC STUDY ON A CYCLOSPORINE DERIVATIVE, SDZ IMM-125 [J].
KAWAI, R ;
LEMAIRE, M ;
STEIMER, JL ;
BRUELISAUER, A ;
NIEDERBERGER, W ;
ROWLAND, M .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1994, 22 (05) :327-365